- Home
- PAI vs DERM Comparison
PAI vs DERM Comparison
Compare PAI & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAI
- DERM
- Stock Information
- Founded
- PAI 1973
- DERM 2014
- Country
- PAI United States
- DERM United States
- Employees
- PAI N/A
- DERM N/A
- Industry
- PAI Trusts Except Educational Religious and Charitable
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- PAI Finance
- DERM Health Care
- Exchange
- PAI Nasdaq
- DERM Nasdaq
- Market Cap
- PAI 121.8M
- DERM 107.0M
- IPO Year
- PAI N/A
- DERM 2021
- Fundamental
- Price
- PAI $12.41
- DERM $5.20
- Analyst Decision
- PAI
- DERM Strong Buy
- Analyst Count
- PAI 0
- DERM 3
- Target Price
- PAI N/A
- DERM $9.50
- AVG Volume (30 Days)
- PAI 25.0K
- DERM 145.7K
- Earning Date
- PAI 01-01-0001
- DERM 11-12-2024
- Dividend Yield
- PAI 4.78%
- DERM N/A
- EPS Growth
- PAI N/A
- DERM N/A
- EPS
- PAI N/A
- DERM N/A
- Revenue
- PAI N/A
- DERM $57,771,000.00
- Revenue This Year
- PAI N/A
- DERM N/A
- Revenue Next Year
- PAI N/A
- DERM $37.38
- P/E Ratio
- PAI N/A
- DERM N/A
- Revenue Growth
- PAI N/A
- DERM N/A
- 52 Week Low
- PAI $10.59
- DERM $2.85
- 52 Week High
- PAI $12.63
- DERM $8.11
- Technical
- Relative Strength Index (RSI)
- PAI 39.69
- DERM 43.96
- Support Level
- PAI $12.62
- DERM $5.00
- Resistance Level
- PAI $12.94
- DERM $5.60
- Average True Range (ATR)
- PAI 0.26
- DERM 0.45
- MACD
- PAI -0.03
- DERM -0.04
- Stochastic Oscillator
- PAI 3.67
- DERM 14.98
About PAI Western Asset Investment Grade Income Fund Inc.
Western Asset Investment Grade Income Fund Inc is a closed-end diversified investment company. The company designed primarily as a long-term investment and not as a trading vehicle. The fund seeks a high level of current income, consistent with prudent investment risk, through investment in a diversified portfolio of debt securities. Its portfolio is invested in securities which may be convertible into or exchangeable for, or carry warrants to purchase, common stock or other equity interests; and preferred stock.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.